Gaming Company PLAYSTUDIOS Executive Reduces Stake Through Scheduled Sales
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PLAYSTUDIOS General Counsel Joel Agena reported multiple insider transactions in a Form 4 filing:
Key Transaction Details:
- Sold 20,490 Class A Common Stock shares at $1.41 (weighted average) on June 20, 2025
- Sold additional 20,490 shares at $1.40 (weighted average) on June 23, 2025
- Transactions executed under a Rule 10b5-1 trading plan adopted March 12, 2025
Current Holdings After Transactions:
- 218,241 direct Class A Common Stock shares
- 291,668 unvested Restricted Stock Units
- 125,000 Performance Stock Units (2025 performance-based)
- 233,043 Stock Options at various strike prices ($0.90-$1.44)
- 28,040 Earnout Shares (contingent on stock reaching $12.50 and $15.00 thresholds)
Positive
- None.
Negative
- General Counsel Joel Agena sold 40,980 shares through a pre-planned 10b5-1 trading plan at average prices of $1.40-1.41, reducing direct holdings by approximately 16% from 259,221 to 218,241 shares
Insider Trade Summary
Net Seller: 40,980 shares ($57,577)
Net Sell
10 txns
Insider
Agena Joel
Role
General Counsel
Sold
40,980 shs ($58K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 20,490 | $1.40 | $29K |
| Sale | Class A Common Stock | 20,490 | $1.41 | $29K |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Performance Stock Units | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Earnout Shares | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 218,241 shares (Direct);
Restricted Stock Units — 125,000 shares (Direct);
Performance Stock Units — 125,000 shares (Direct);
Stock Options — 46,609 shares (Direct);
Earnout Shares — 28,040 shares (Direct)
Footnotes (1)
- This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025. This trading plan was previously disclosed in the Issuer's Quarterly Report on Form 10-Q filed on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.44 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.43 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. On March 7, 2025, the Reporting Person was granted 166,667 unvested Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. The Restricted Stock Units are scheduled to vest as follows, subject in each case to the Reporting Person's continued employment with the Company through the applicable vesting date: 41,667 Restricted Stock Units vesting on May 15, 2025; 41,667 Restricted Stock Units vesting on January 15, 2026; 41,667 Restricted Stock Units vesting on January 15, 2027; and 41,666 Restricted Stock Units vesting on January 15, 2028. On March 11, 2024, the Reporting Person was granted 358,335 unvested Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. The Restricted Stock Units are scheduled to vest as follows, subject in each case to the Reporting Person's continued employment with the Company through the applicable vesting date: 66,667 Restricted Stock Units vesting on May 15, 2024; 125,000 Restricted Stock Units vesting on May 15, 2025; 83,334 Restricted Stock Units vesting on May 15, 2026; and 83,334 Restricted Stock Units vesting on May 15, 2027. On March 7, 2025, the Reporting Person was granted 125,000 unvested Performance Stock Units. Each Performance Stock Unit represents the contingent right to receive, upon vesting and settlement, up to one share of Class A Common Stock. The actual number of shares of Class A Common Stock to be issued upon vesting of such Performance Stock Units will be determined based on, and will be contingent upon, the achievement of certain pre-established performance metrics, as determined by the Compensation Committee of the Company's Board of Directors, for the fiscal year ending December 31, 2025. Payable in two equal tranches if the closing price of the Class A Common Stock exceeds $12.50 and $15.00 per share, respectively, for any 20 trading days within any 30-trading day period commencing on or after the 150th day following the closing (the "Closing") of the business combination pursuant to the Agreement and Plan of Merger, dated as of February 1, 2021, by and among Acies Acquisition Corp., Catalyst Merger Sub I, Inc., Catalyst Merger Sub II, LLC, and Old PLAYSTUDIOS, and ending no later than the five-year anniversary of the Closing (the earnout consideration will also vest based on the price targets in connection with a sale of the Issuer).
FAQ
What is Joel Agena's remaining MYPS stock position after the June 2025 sales?
After the reported transactions, Joel Agena directly owns 218,241 shares of MYPS Class A Common Stock. Additionally, he holds various derivative securities including 291,668 Restricted Stock Units, 125,000 Performance Stock Units, 233,043 Stock Options at various strike prices, and 28,040 Earnout Shares.
Were MYPS insider Joel Agena's stock sales planned in advance?
Yes, the sales were made pursuant to a Rule 10b5-1 trading plan that Joel Agena adopted on March 12, 2025. This trading plan was previously disclosed in the company's Quarterly Report filed on May 9, 2025.
What are the vesting terms for MYPS General Counsel's recent RSU grants?
Agena received two recent RSU grants: 1) 166,667 RSUs granted on March 7, 2025, vesting in tranches through January 15, 2028, and 2) 358,335 RSUs granted on March 11, 2024, vesting in tranches through May 15, 2027. Both grants are subject to continued employment with MYPS through the applicable vesting dates.
What performance conditions apply to MYPS executive Joel Agena's PSU grant?
On March 7, 2025, Agena was granted 125,000 Performance Stock Units (PSUs). The actual shares to be issued will be determined based on achievement of pre-established performance metrics for fiscal year 2025, as determined by the MYPS Board's Compensation Committee.